: Demonstrated similar pharmacodynamic characteristics and toxicity profiles to the reference product.
📢
For full prescribing information and format items, clinicians can reference the FDA Center for Drug Evaluation and Research records. 125545
#Biosimilars #FDA #Hematology #PharmaNews #HealthcareInnovation Clinical Spotlight: Retacrit (epoetin alfa-epbx) 125545